The AMR Studio
The AMR Studio is a podcast dedicated to current multidisciplinary research on antimicrobial resistance. It is hosted by the Uppsala Antibiotic Center and co-led by Eva Garmendia and Elin Fermér. The podcast explores various aspects of antimicrobial resistance from a scientific perspective.
Avsnitt
Ep 63: Enrico Baraldi & antibiotics' markets. Colonization of the microbiome. 2025 GLASS report.
We hear a lot about the need for new antibiotics. But what about the ones we already have?In this episode, we sit down with Enrico Baraldi to explore the hidden world behind antibiotic markets. You hear how supply chains break, why withdrawals happen, and what it really takes to keep essential drugs available in countries like Sweden. You also get a look at the methods behind this research, the co
Ep X13: Antibiotic Resistance & Cancer
A child in remission. A sudden fever. The antibiotics stop working. In this episode at The AMR Studio we dive into the hidden link between cancer and antibiotic resistance: why cancer patients are especially vulnerable, how antibiotics in oncology affect resistance, and what researchers are doing to change it. In this episode, communications intern Jose Rodriguez Capel, bring us the connection bet
Ep 62: Tove Fall, the microbiome & study design. The vaginal resistome. Metallo-beta-lactamase inhibitors.
Happy start of the summer, dear listeners! In this episode before our break, we interview Professor Tove Fall, a veterinarian turned epidemiologist working to unveil the molecular connections determining health and sickness. We learn about her path, how she developed her career to fit her interests and strong skills, and how important study design is. In the news section we cover a recent review a
Ep 61: Elias Arnér, redox & EbsArgent. Ceftazidime-avibactam for P. aeruginosa treatment. FusB-mediated resistance.
In this episode, we bring you an interview with Professor Elias Arnér from the Karolinska Institute. After a long international career in redox biology, Professor Arnér became CEO of Thioredoxin Systems, the company behind a potential new antibiotic with a novel target and mode of action: EbsArgent. We explore his background, the lessons he has learned, and what makes this new drug candidate so un
Ep 60: Till Bachmann & providing solutions for AMR. AI to help tackle AMR. Horizontal gene transfer drivers.
Welcome to episode 60th! YES, 60!! Celebrate this rounded number with us and Prof. Till Bachmann in an inspiring interview where we learn Till’s journey, explore how diagnostics are an essential part of managing AMR and infection treatment, and revisit the DOSA project. This multidisciplinary & one-health-focused multi-country endeavor provides solutions to a neglected disease: UTI.In the news
Ep 59: Vance Fowler & the Antibacterial Resistance Leadership Group. Pipeline for studying AMR in pig farms. Commentary on public involvement.
Welcome to a new episode of The AMR Studio! This month, we bring you an interview with MD Dr. Vance Fowler, co-lead of the Antibacterial Resistance Leadership Group (a.k.a. ARLG). In our chat, we learn how Dr. Fowler came into AMR, the decades-long work they’ve been doing with MRSA research, and the ins and outs of the ARLG.
In the news section, we proudly present the recent published paper by our
Ep 58: Evangelos Mourkas, campylobacter & urbanization. Probiotics & AMR. Plasmid-chromosome cross-talk.
Welcome to 2025! We are so happy to be starting one more year with you, our 8th year! On this episode, we bring you the story and work of Dr. Evangelos Mourkas, a veterinarian-turned-computational biologist who loves to also do the field work himself! In this interview, we dive deep into his motivators, reflections, and how campylobacter can be used as a marker for AMR spread.On the news section,
Ep 57: Olivier Rubin & AMR governance. November update. Rifaximin & daptomycin cross-resistance.
Hitting this November month with a very relevant topic, Global Governance! In this episode, you can listen to an interview with had with Prof. Olivier Rubin, from Roskilde University in Denmark, about the social dimensions of AMR, and how AMR is a so-called “creeping crisis” globally. Olivier has years of experience researching slow-onset crisis such as famine and climate change, and has in the re
Ep 56: Eva Krockow, a psychologist in AMR. Chat GPT as a diagnostic tool. Metaphors in the AMR discourse.
We are finally back from our looooong break! Welcome, to another episode of The AMR studio, now again with co-host Elin Fermer at the mic after her maternity break. We are so thrilled to bring you our conversation with Eva Krockow, a psychologist working with decision making, risk communications, and language. We learn about her interests and path, and what’s on the pipeline for her.
On the news,
Ep X12: Catching up with friends at ESCMID Global 2024
Coming to your right live from ESCMID Global 2024! Last month, the we participated in the most massive conference ever, ESCMID Global (previously known as ECCMID) in beautiful Barcelona, this year counting with 18.000 registered attendees (yes, you read that right!). We took the opportunity to sit down to catch a breath, and catch up, with some friends and colleagues whom we have not seem for a wh
Ep 55: Alberto Antonelli & testing diagnostics. Failed AMR language. Resistance begets resistance.
Welcome to April dear listeners! In this episode, we bring you an interview with Dr. Alberto Antonelli, researcher at the University of Florence doing a very important job: taking care of testing and optimizing new diagnostic technologies in high AMR-impacted settings such as Italy. Tune in to listen his path to his research field, the challenges he faces and what we should be looking forward to i
Ep 54: Suzanne Ruhe-van der Werff & surveillance. A preorganized antibiotic. Engineering probiotics.
After a short hiatus, we are back with our regular episodes, and with a pop-up guest co-host! Tune in to our first of 2024, where we learn about surveillance and use of health data for its automation with Suzanne Ruhe-van der Werff, research specialist at Karolinska Institutet. In this interview, we learn about Suzanne’s path from parasitology to infection prevention and control and talk about the
Ep X11: Community Engagement in AMR.
How can we prevent antibiotic resistance together? For this World AMR Awareness Week 2023, we focus on this togetherness by highlighting Community Engagement in AMR, with 8 guests bringing us their perspectives on what communities and community engagement are, how community engagement can be essential on the road to mitigate the effects of resistance globally, and what they hope happens in this ar
Ep 53: Álvaro San Millán & plasmids. AMR terminology. Co-designing AMR solutions with communities.
Welcome to November! In this episode, we bring you the work of Álvaro San Millán, group leader at the National Center for Biotechnology in Spain, where he researches the role of plasmids in antibiotic resistance. In this interview, among other things, we talk about how understanding plasmid biology can lead to new ways of tackling resistance, and learn about his impressions of being a young group
Ep 52: Jakob Altgärde, an ID physician. Antibiotic combinations for gram positives. The Antibiocene.
Welcome to a new episode, albeit the slight delay! Tune in this October to listen to Elin’s first interview ever! She had the chance to sit down and talk to Jakob Altgärde, infectious diseases physician with experience in hospital work around infections and resistance in both Sweden and Nepal. With him, we learn how an ID physician works day-to-day, and the main differences between Sweden and Nepa
Ep 51: Cassandra Quave & ethnobotany. Antibiotics & CRE growth in the gut. Sub-MIC & river biofilms.
We are back from summer break with a new discipline at our studio, ethnobotany! Click play to hear about the work of ethnobotanist Cassandra Quave, a.k.a. The Plant Hunter, in her quest to find new antibiotics, anti-infectives, and biofilm inhibitors in plants used in traditional medicines around the world. We learn with her about the vast chemical world still yet to be studied, and how a horizont
Ep 50: Sophia Wood & an AMR exhibition. Preventing resistance evolution. Policy briefs at EU & WHO.
Welcome to our July episode, just before the holidays! This month, we bring you an interview with Sophia Wood, designer, and teacher at the Beckmans College of Design. Sophia led a group of design students through the “interdisciplinary waters” as they prepared to make an exhibition about AMR which they named “Are We There Yet?”. Tune in to learn about her background, their process, and what this
Ep 49: Dame Sally Davies & global governance. AI for antibiotic discovery. Nanomovement diagnostics.
June comes with a bang! Tune in to this episode to hear the insights of the incomparable Dame Sally Davies, former UK Chief Medical Officer and current UK Special Envoy on Antimicrobial Resistance. We chat with her about her path to being a global advocate on AMR, the need for better global governance, and what her vast experience has taught her. Talking to her was a truly inspirational experience
Ep 48: Anna Sjöblom & ReAct. Population ab use & the gut microbiome. Host-specific plasmid evolution
Spring is back in Sweden, and so are we in your ears! This month of May we bring you an interview with Anna Sjöblom, director of ReAct Europe, a branch of an international organization working to promote and deliver action on antibiotic resistance. We learn about Anna’s background, the path that led her to ReAct, and many of the activities that ReAct has done and have currently ongoing.
In the ne
Ep X10: Live from ECCMID23!
The AMR Studio goes on a field trip! Join our hosts Eva & Elin on their adventures in Copenhagen at the European Congress of Clinical Microbiology and Infectious Diseases (a.k.a. ECCMID) this year. From 15th to 18th of April, more than 13.000 people came together to talk about the most recent advances in infectious diseases, including antimicrobial resistance. Listen to this special episode to pee
Ep 47: P. Rönnholm & L. Cigolot. On-site pharmacies. Collateral phenotypes in M tuberculosis.
In this episode, we bring you a double interview with two women deeply involved in patient advocacy and AMR. Tune in to hear the story of Pernilla Rönnholm, chair and founder of Mirakel, an association advocating for premature babies and their families, and the work that Laura Cigolot is doing within the AMR patient group, a cross-European initiative to bring awareness of AMR to many kinds of pati
Ep 46: Alison Prendiville & service design. Antimicrobials in food animals. Bacteriuria & ICU stays.
Ready for a new episode? This month of March we bring you an interview with Alison Prendiville, Professor of Service Design at London Colleague of Communication, University of the Arts, London. With Alison, we learn the importance of co-creation and design when working with implementation, and how crucial communication is in various forms for interdisciplinary research. Tune in to learn the journe
Ep 45: Nicola Gale & sociology. Mycobiota & salmonella infections. Use of imagery in global health.
Welcome to 2023! Tune in to this episode to hear the work and experience of Professor Nicola Gale, a sociologist with long experience in interdisciplinary work. We learn with her about sociological work, how she applies risk work theory to AMR, and her insights into the intersection between the application of guidelines and the personal experience of healthcare workers. In the news section, we bri
Ep44: Jonas Fuks & the coordination group. CRP test and conversation analysis. ProQ and persistence.
Welcome to this last episode of 2022! After a super busy and important month of November, we bring you a new episode with quite a Swedish perspective. On November 17th, we attended the Swedish Antibiotic Forum event and were able to talk to Jonas Fuks, an analyst at the Public Health Agency of Sweden, about the 10-year anniversary of the forum and the group behind it, the Swedish intersectoral coo
Ep X9: Antibiotic Smart Sweden
Can you imagine a society where every individual and organization acts and works in a way to reduce the impact of antibiotic resistance? A society where everyone is aware of the problem and engaged in trying to resolve it? How would that look to you? For this year’s World Antimicrobial Awareness Week we bring you the Antibiotic Smart Sweden initiative, a mission-oriented approach to system change,
Ep 43: Vaughn Cooper & biofilms. Tigecycline resistance. Chromosomal Hybrids. Pneumococcal vaccine.
Coming in hot for this November month! Today we have with us Dr. Vaughn Cooper, professor and director of the Center for Evolutionary Biology and Medicine at the University of Pittsburgh. Tune in to learn about his deep love for evolution, his background at the Lenski lab, and his current work studying biofilms.
For the news section, we first bring you Jenny's recent paper looking at the evolutio
Ep 42: Björn Rönnerstrand & political sciences. Non-prescribed Abs. Consensus & contextual factors.
In this October episode, we bring you an interview with Dr. Björn Ronnerstrand, a political sciences researcher who brings to us how political sciences and AMR intersect and his work on the possible role of the EU in AMR policy. We also discuss the need for more political science research in this area and how AMR can be a fantastic starting point for theoretical work, not just practice. In the new
Ep 41: Bruce Blough, Elliott Pauli & CC4CARB. Cefiderocol resistance. Studying biofilms in space.
In this September episode, we bring you a 2-for-1 interview! Listen to Bruce Blough & Elliott Pauli talk about the Chemistry Center for Combating Antibiotic Resistant Bacteria (CC4CARB) project they are working on, an innovative chemistry center focused on the synthesis, acquisition, and distribution of rationally designed, focused libraries free-of-charge to the global scientific community for us
Ep 40: John Jernigan & decolonization. Paper AST. A potential new Giardia treatment. AMR vaccines.
Welcome back to the AMR studio after our short summer break! For this episode, we are bringing you an interview with Dr. John Jernigan, physician and director of the Office of Hospital Acquired Infections Prevention Research and Evaluation Division at the CDC. We talk with him about the new innovative approaches that the CDC is working on when it comes to AMR, with a focus on decolonization. Learn
Ep 39: Vanessa Carter & patient advocacy. A stewardship game. Evolution of antibiotic tolerance.
Welcome to this June episode! This month we bring you a story and theme we consider very important in the efforts to control AMR: patient advocacy. Tune in to listen to the story of Vanessa Carter, a patient who suffered from the consequences of antibiotic resistance during her recovery after a car accident, and saw first hand the shortcomings of how resistance is communicated in healthcare. We ta
Ep 38: Carl-Fredrik Flach & sewage surveillance. Chlorination & microbiome. C. diff zoonotic spread.
Happy month of May! Happy month of May! In this one-health oriented episode we bring you the work of Carl-Fredrik Flach, who is an expert on sewage surveillance applied to AMR. In this interview, we chat with him about the overall role of the environment in AMR, what its dimensions are, and learn how sewage surveillance could be an asset to drive empirical treatment, especially in poor-resource se
Ep 37: Celia Souque & evolution + outreach. Colistin and silver. Qualitative research on AMS.
Welcome to our slightly delayed April episode! For this one, we bring you an interview with Dr. Celia Souque, an evolutionary biologist with a love for board games. We talk with her about evolution, antibiotic resistance and her great outreach board game project "Drugs vs. bugs" where she worked to design not only an educational tool, but also a beautiful, fun, and engaging game for anyone to play
Ep 36: Michael Craig & the CDC on AMR. Global antimicrobial consumption. Metronidazole resistance.
For this month of March, we bring you an interview with Mr. Michael Craig, director of the CDC's Antibiotic Resistance Coordination and Strategy, where we learn more about the role and work of public health agencies, how the CDC works in its strategy against antibiotic resistance, and the importance of prevention. In our news section, we present to you a recent publication on how the WHO antimicro
Ep 35: Christer Malmberg & rapid diagnostics. MALDI-TOF machine learning. Global burden of AMR.
Happy 2022 to you all! We are glad start a new year with you with this episode. This time, we bring you an interview with our first UAC PhD graduate, Christer Malmberg, who defended his industry-PhD thesis last year, where he developed a new rapid method of testing antibiotic susceptibility. We talk about his experience throughout his studies, what this new method brings to the table, and what he
Ep 34: Laura Piddock & her career in AMR. A new synthetic ab. Mining the human proteome for AMPs.
Welcome to another regular episode at The AMR Studio! We are happy to be back with our interviews, and we bring you today the work and broad experience of professor and GARDP's Scientific Director Laura Piddock, an incredible scientists and AMR policy advocate. She shares with us her path, insights and experiences, and inspires us for the future. In the news section, we have for you two recent art
Ep X8: WAAW21 - Awareness from and to the AMR community. Part 2.
Welcome to the second part of this special series with occasion of the antimicrobial week. To raise awareness from and to the AMR community, today we bring you another four researchers at the Uppsala Antibiotic Center that focus their work beyond the lab and development of new treatments. Listen to learn what they are working on, from farms to hospitals, and what they want you to learn!
Check out
Ep X8: WAAW21 - Awareness from and to the AMR community. Part 1.
Happy World Antimicrobial Awareness Week! For this year's campaign theme “Spread Awareness, Stop Resistance” we thought to tackle the concept of “awareness” from a different angle. We believe that awareness of the work of others within the AMR community is also important, and that sharing the understanding, viewpoints, and perspectives of AMR professionals can have a great impact on the work that
Ep 33: Manica Balasegaram & the work of GARDP. AMR & patients with cancer. CRISPR-Cas antimicrobials
Welcome to another month with the AMR Studio! For this occasion, we sat down with Dr. Manica Balasegaram to talk about his path from his years as a physician to his current position as director of the Global Antibiotic Research & Development Partnership (GARDP). Listen to learn how he entered the AMR world and the aspirations and current work done at GARDP. This was such an inspirational interview
Ep 32: Anna Dumitriu & bioart. Access to antibiotics in high-income countries.
Happy September to you all! Welcome to another episode of The AMR Studio, this time featuring an interview with artist Anna Dumitriu. Tune in to listen to how Anna became so interested in bacteria and antibiotic resistance that she decided to make it a central part of her artwork. We also talk about the implications of science in art, how art and science can help one-another and what she aims to c
Ep 31: David Hyun & the work of The Pew Charitable Trusts on AMR. Antibiotic treatment & probiotics.
Happy month of August to you all! In this episode, we feature an interview with Dr. David Hyun, director of the antibiotic resistance project at The Pew Charitable Trusts. We start by talking about David's journey to his current position and Pew's approach to support policy change and research on AMR in the United States, before diving into their latest publication looking at antibiotic prescripti
Ep 30: Luisa de Sordi & phages. The impact of travel on resistance. New ABR viewpoint & more news.
Welcome to another episode of The AMR Studio! Dive in to learn the story of Dr. Luisa De Sordi, a microbiologist working with bacteriophages and gut bacteria to study the relationship between our digestive system, the microbiota and their associated phages. We also go through a brief history of phage therapy and its future ahead! On this occasion, we also bring you a packed news section covering a
Ep 29: Ana Brochado & high through-put in AMR. Candida albicans infections. Role of host immunity.
Happy month of June to you all, and welcome to another episode of The AMR Studio! Tune in to our interview with Dr. Ana Rita Brochado, group leader at the University of Würzburg and looking into how antibiotic combinations affect bacterial growth using high-throughput methods. You will listen to an insightful and inspiring chat with a young, successful researcher that knows the power of collaborat
Ep 28. Rachel Irwin & the visual culture of AMR. Current AB pipeline. Neonatal sepsis in LMICs.
Welcome to another month at The AMR Studio. In this one, we bring you Rachel Irwin, an anthropologist that has recently focus on studying the visual culture of AMR. In this interview, you'll catch us talking about her work, but also about her path into AMR, the hurdles and happy stories, and some very interesting personal insights. In the news, we cover the latest WHO report, looking into the curr
Ep X7: How do we change behaviour around antimicrobial resistance?
Welcome to this special episode at The AMR Studio in collaboration with Drug Safety Matters podcast. As a follow up to Uppsala Health Summit on “Managing antimicrobial resistance through behaviour change” we spoke to three key participants – Otto Cars, Eldar Shafir and Vanessa Carter – to learn more. We talked to them about how the COVID-19 pandemic might affect AMR globally, how the context aroun
Ep 27. Helle Aagaard & AMR advocacy. Stewardship & access plans. Resistance & artificial sweeteners.
Welcome back to The AMR Studio dear listeners. This month, we bring you an interview with Helle Aagaard, deputy director at ReAct, who has recently, as lead author, published a new report looking into sustainable solutions for access to effective antibiotics for everyone, everywhere. Listen to her story to learn more about her background and entry into policy and advocacy, and some insights into t
Ep 26. Mirko Ancillotti & bioethics. Resistance to antibiotics vs. vaccines.
Starting March the best way, with an AMR Studio episode! This time we bring you an old friend of the podcast, Mirko Ancillotti, right before his doctoral defense, talking to us about his path from philosophy and ethics into biology and public health. We also converse about his latest results on public preferences regarding antibiotic treatment, and about public misconceptions when it comes to anti
Ep 25. Linus Sandegren & mobile genetic elements. Identifying resistance origins. Reimbursing ABs.
Welcome, bienvenidos, välkommna to 2021 dear listeners! In this kickstart episode after the New Years hiatus we bring you an in-depth interview with Linus Sandegren, coordinator at UAC, but also researcher and teacher at Uppsala University. Learn how his early research in a topic quite unknown led him to work on AMR, and what his group is currently studying. He also updates us on how the center ha
Ep 24. Lindon Moodie & organic chemistry. Diagnostic usage behavior in India. AMR Voices.
Welcome to our last 2020 episode, listeners! For this occasion, we were thrilled to interview the last of our associate senior lecturers, Dr. Lindon Moodie. His path through the field of organic chemistry has brought him to AMR recently and in this conversation we learn how he is approaching the task of finding new antibiotics. In the news section, we close the year with a recent publication by on
Ep X6. AMR, Human Behavior & the Uppsala Health Summit
Welcome to our special contribution for World Antimicrobial Awareness Week 2020! In this episode we focus on the aspect of human behaviour in the AMR context. Why is it important? How can we motivate people to change the way the relate to antibiotics? What role do we all play in this? This are the very question that the Uppsala Health Summit will focus on next spring, and the questions that we bri
Ep 23. Teresa Zardán & nanotechnology in AMR. The PASTEUR act. AMR update outlook compilation.
Welcome to November at The AMR Studio! This month we bring you the cutting-edge research conducted by one of the associate senior lecturers at the UAC, Dr. Teresa Zardán Gómez de la Torre, who is working on developing an easy, affordable, and stable new diagnostic tool based on nanotechnology. Listen to how nano-materials could be the next answer to provide low-resources settings with reliable tes
Ep 22. Olof Lindahl & business studies in AMR. Testing Ab combinations. Plasmid stability evolution.
This month we bring you the work and career of Dr. Olof Lindahl, one of the associate senior lecturers at UAC, working in the field of business studies applied to AMR. In the news section, we present to you a new innovative method to test how antibiotics combinations work, and cover a recent article looking into the evolution of plasmid stability in relation to antibiotic treatment. We hope you en
Ep 21. Ursula Theuretzbacher, an independent AMR scientist. The AMR Action Fund. Renaming AMR.
Welcome back to The AMR Studio after the summer vacation! ☀️ Today we bring you a long-waited interview with CEFAIA's founder & AMR scientist Dr. Ursula Theuretzbacher. Learn about her career, current interests and work through our conversation, very enlightening! In the news section we cover the current launching of a big international collaborative & non-profit project, The AMR Action Fund, and
Ep 20. Peter Jørgensen & AMR resilience. Public AMR explanations. Update on teixobactin.
July is here, and so is the heat! This month at The AMR Studio we bring you the work of Dr. Peter Jørgensen, from the Stockholm Resilience Center. Listen to this episode to learn about what resilience means, how it is related to AMR and how an evolutionary biology perspective can help achieve a more sustainable future. In the news section, we cover a recent published work looking into the backgrou
Ep 19. Johan Bengtsson Palme & AMR in the environment. Colistin pharmacokinetics. AB use in LMIC.
We welcome the summer at The AMR Studio! This month, we bring you a deep conversation with Dr. Johan Bengtsson Palme from the CARe center in Gothenburg about the role of the environment in the AMR problem and how his group focuses on studying it. Dive deep into this essential part of "one health" that is so frequently talked about. In the news, we feature two recent UAC articles! Our PhD student V
Ep 18. François Lebreton & bioinformatics. Machine Learning approaches in AMR.
May the 4th be with you! Welcome back to our studio, fellow listeners. We are thrilled to bring you an episode looking into some of the newest approaches within AMR research. First, we feature an interview with bioinformatician Dr. François Lebreton, whose primary work consists of using DNA sequence analysis to study outbreaks of resistant strains. In the news section, we talk about machine learni
Ep 17. Kristina Osbjer & National Action Plans. A new rapid AST. Ab treatment & diabetes type I.
Hi there! Whether you are still at work and doing normal life, or staying home during these difficult times, we got you! Welcome to another episode full of relevant topics around antibiotics and resistance. This month we have an interview with veterinarian Dr. Kristina Osbjer, whose work in Cambodia has helped to set up a multi-sectoral national action plan following up recommendations from the gl
Ep 16. John Rex & Antibiotics R&D. AMR in Newspapers. Collateral sensitivity mechanisms.
Hi listeners! New month, new episode at The AMR Studio. Spring is around the corner and today we bring you an enthusiastic and very eloquent interview with Dr. John Rex, a former infectious diseases doctor that currently works, as he puts it, in developing new drugs, making development of new drugs possible, or making sure people get paid to develop new drugs. Join us in a deep conversation about
Ep X5. Hacking AMR 2019.
Welcome to another month at The AMR Studio. We are happy to bring you something special this time: a chronicle of a very cool event we were at this past December, a hackathon! Press play to learn what a hackathon is, the projects worked on during the weekend, impressions from some of the people attending, and of course, who won the grand prize! Next month we will be back to our regular structure,
Ep 15. Jasper Littmann & policy on AMR. Preclinical pipeline and development challenges.
Welcome to the "new" roaring 20s! Celebrate the new year and decade with us by listening to our latest episode, featuring an interview with Dr. Jasper Littmann, Specialist Director for Strategy and Development at the Norwegian Institute of Public Health. In this interview, we learn how an ethicist works when translating knowledge into action within policy making, the challenges in communicating wi
Ep 14. Catherine Will & messaging on AMR. Reframing Resistance. Reports update.
Welcome back to our regular episodes! Join us and Catherine Will, from the University of Sussex, in a conversation about how people understand the messages about AMR and how the different mobilizations, stewardship measures, and campaigns around antimicrobial resistance attend to questions of inequality and social injustice. In our news section, we summarize the recent published work by the Wellco
Ep X4. Communicating AMR globally. Amy Reid.
Here we bring you our second (and last) piece of the special on communicating AMR for this year's awareness week. Click play to listen to Amy Reid, from the World Health Organization working at the AMR team, being interviewed about their work dynamics, strategies, challenges and outlooks when it comes to increase global awareness on AMR. WHO is the main orchestrator of this global awareness annual
Ep X3. Communicating AMR in Sweden. Gunilla Stridh Ekman & Ulrica Dohnhammar.
Welcome to this first part of our special series for the World Antibiotic Awareness Week 2019 campaign! In this episode you will briefly be introduced to the Swedish health care system, and then you will listen to two interviews of people working with communicating AMR in the Swedish context. First, we have Gunilla Stridh Ekman from STRAMA, presenting the work done mostly at the local level around
Ep 13. Claas Kirchhelle & a historian's role in AMR. Review of progress on Antimicrobial Resistance.
Welcome to our first anniversary episode! Turning 1 with you by featuring the interview we did with Dr. Claas Kirchhelle, a historian at the University of Oxford. Tune in to get a peek into how historians like him contribute to the study and communication of AMR. Also, we briefly cover the recent publication looking into the progress done on the gobal Antimicrobial Resistance work, after the recom
Ep 12. Christian Munthe & AMR Ethics; ethical prescriptions; persisters & plasmids in the gut
Dive in and learn about the roll that ethics and philosophy can have within AMR with Dr. Christian Munthe (currently part of the Centre for Antibiotic Resistance Research -CARe-) in this month's episode of The AMR Studio. With his background in practical philosophy, Dr. Munthe works with translating thoughts into actions when it comes to the various dilemmas that AMR poses regularly. In the news s
Ep 11. Caroline King & the humanities on AMR; screening experiences; non-traditional therapeutics.
For this September episode we bring you an interview with Dr. Caroline King, an academic with a nursing background working with the humanities and social sciences in hospital settings. Learn about her background and current research topics looking into patients and healthcare professionals facing AMR. In the news sections you'll get an in depth analysis of one of Dr. Kings recent articles analyzin
Ep 10. Fredrik Almqvist, chemistry on AMR; treating heteroresistance; policy interventions reviewed
Happy August! Join us this month to learn about the career of Fredrik Almqvist, a chemist in AMR with a big passion for education and multidisciplinary research environments. In the news section we bring you a recent article looking into how antibiotic combinations can help treatment of infections presenting heteroresistance; and a thorough review article mapping the current evaluated AMR policy i
Ep 9. Chantal Morel & health economy; nonprofit antimicrobials; reversing resistance in tuberculosis
Summer episode right here! This month we bring you a thorough discussion we had with Chantal Morel about the economic situation of the antibiotic and diagnostics markets. Why is it no longer working? Can it be changed? In our news section, we talk about a new perspective on how non-profit organizations can help solve these market issues; and a very cool research article proving that resistance in
Ep 8. Gerry Wright, a biochemist in AMR; a phage-therapy treatment; an emergent fungal infection.
One more month at the AMR Studio, we bring you a heartwarming conversation around AMR experiences and work. This month we feature an interview we did with Gerry Wright, a biochemist turn microbiologist working on drug development,and that personally had to face the reality of AMR. In our news section we bring you the happy story of a cystic fibrosis patient successfully treated using phage therapy
Ep X2. Young researchers at the European Congress of Clinical Microbiology & Infectious Diseases.
Welcome to another live episode at The AMR Studio! This time we are coming to you live from ECCMID2019, the annual European Congress of Clinical Microbiology and Infectious Diseases. We had the pleasure to interview 5 young researchers coming from around the globe (Australia, Norway, Spain, France & the USA) about their current projects and work. Listen to this episode to learn more antibiotic res
Ep 7. Ayako Ebata & agricultural economics; report to the UN on AMR; targeted killing in bacteria.
Welcome back to the AMR Studio. This month we bring you an insightful conversation with Dr. Ayako Ebata, from the Institute of Development Studies. She is an agricultural economist that has recently been working across Asia, mostly in Myanmar and India understanding the antibiotic market situation in the agricultural sector. In our news section we talk about the recent report on AMR released to th
Ep 6. Sophie Helaine & bacterial persistence; breakpoint discrepancies; ABR in the media.
Here we are one month more! In this episode you have the chance to learn about antibiotic persistence and the differences between this and antibiotic resistance with Dr. Sophie Helaine from the Imperial College London. In our news section we talk about a recent report published on the discrepancies of breakpoints between different antibiotic susceptibility systems, and a very good media article ab
Ep X1. Mirko Ancillotti & public awareness of antibiotic resistance.
Special extra episode! Coming to you live from Uppsala's SciFest 2019, here you can listen to the interesting discussion we had with Mirko Ancillotti, from the Centre for Research Ethics and Bioethics at Uppsala University. Learn with us about the different perceptions and susceptibilities of the Swedish public regarding antibiotic resistance. Check relevant links and material at www.uac.uu.se/the
Ep 5. Steven Hoffman & international law; heteroresistance; AMR funding.
Join us this time to learn about the journey of Professor Steven Hoffman, a lawyer specialized in international law working on AMR. In the news sections we will be talking about heteroresistance, a quite sneaky type of resistance; and about a dialogue paper dwelling on the global AMR financing situation. Check relevant links and material at www.uac.uu.se/the-amr-studio/episode5/. Follow our update
Ep 4. De Lima Hutchison & anthropology of microbes; fecal pollution & AMR; plasmids in Acinetobacter
Welcome to a new episode of The AMR Studio! This time, we have the interview we did with Dr. Coll De Lima Hutchison from the London School of Hygiene and Tropical Medicine. We chatted with him about his work in anthropology, and got a good insight into the importance of cultural and historical backgrounds when trying to change behaviours. In our news section we bring to you the latest research on
Ep 3. Anne Kveim Lie & Antibiotic Futures; Antibiotic stewardship in humans and animals.
In this episode, we feature an interview with medical historian Dr. Anne Kveim Lie from the University of Oslo. In her interview and our discussion, you will learn about how looking at the past can help us understand our present better, and how past futures have influenced the history of antibiotics up to today. In our news section, we will be talking about antibiotic stewardship in both human and
Ep 2. Kevin Outterson, CARB-X director; a new anti-gonorrhoeal drug; AMR burden in Europe.
In this episode we feature an interview with the director of the CARB-X program, Professor Kevin Outterson, and inaugurating our news section, we bring to you an exciting new drug to treat gonorrhoeal infections and the most recent estimations of AMR burden in Europe. Check relevant links and material at http://uac.uu.se/the-amr-studio/episode2/. Follow our updates on twitter on twitter.com/uac_uu
Ep 1. Antibiotic Resistance, the Uppsala Antibiotic Center & Antibiotic Awareness Week.
We launch our podcast series on antimicrobial resistance research, “The AMR Studio”, during the World Antibiotic Awareness Week 2018. In this episode we feature a short introduction on what antibiotics and antibiotic/antimicrobial resistance are, an in-depth interview with the management team of the Uppsala Antibiotic Center and we talk a bit about what the World Antibiotic Awareness Week is. Rele
